John Crowley

2022

In 2022, John Crowley earned a total compensation of $1.4M as Chief Financial Officer at Fusion Pharmaceuticals, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,146
Option Awards$772,909
Salary$458,274
Other$48,684
Total$1,443,013

Crowley received $772.9K in option awards, accounting for 54% of the total pay in 2022.

Crowley also received $163.1K in non-equity incentive plan, $458.3K in salary and $48.7K in other compensation.

Rankings

In 2022, John Crowley's compensation ranked 2,306th out of 5,756 executives tracked by ExecPay. In other words, Crowley earned more than 59.9% of executives.

ClassificationRankingPercentile
All
2,306
out of 5,756
60th
Division
Manufacturing
1,253
out of 3,133
60th
Major group
Chemicals And Allied Products
559
out of 1,419
61st
Industry group
Drugs
514
out of 1,320
61st
Industry
Biological Products, Except Diagnostic Substances
124
out of 291
57th
Source: SEC filing on April 27, 2023.

Crowley's colleagues

We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2022.

2022

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2022

Eric Burak

Fusion Pharmaceuticals

Chief Technology Officer

News

In-depth

You may also like